Genomics Giant Illumina to Grow Singapore Workforce by Up to 25 Per Cent
Published
Illumina, a major American genomics company, plans to increase its workforce in Singapore by around 20 to 25 per cent over the next five years. The company currently employs about 1,700 people in the city-state, so this expansion would add several hundred new jobs.
The company's decision strengthens its research and development (R&D) activities in Singapore. Illumina develops tools and technologies used to read and analyse DNA, and its products are widely used in medical research, disease diagnosis and healthcare. By investing more in local R&D, the company is building on its existing presence in the country.
The move is also a sign of Singapore's continuing efforts to attract high-value industries such as biotechnology and life sciences. The Economic Development Board, the government agency that promotes investment in Singapore, has been working to develop the country as a centre for healthcare innovation. Expansions like this one can create skilled jobs for local workers and help the country's economy diversify.
The company has not yet shared full details of which roles will be created or when each stage of the expansion will take place. Further updates are expected as the plans develop over the coming years.
Sources: Singapore Economic Development Board (EDB)
More Singapore news
- Most Singapore Tech Workers Now Based Outside the Tech Sector, Report Finds
- Korean Students Visit Singapore to Explore Tech and Industry Careers
- French AI Firm Mistral Expands Singapore Operations with New Science Hub
- Hawaii Researcher Joins Singapore Roundtable on Outer Space and Security
- Chinese Vice Premier Ding Xuexiang to Visit Singapore for Bilateral Talks
- Singaporeans Feel Left Behind as AI Push Continues
- Sokin Launches Full Operations in Singapore Under MAS Licence
- Singapore Experts Gather to Explore Better Health Data Standards